Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Extreme Language Ultra-High Potency
The newest generation of small-molecule therapies bring containment needs well beyond those of conventional HPAPIs. What does this mean for the pharma lexicon – and the pharma landscape? read more
An Interview With Brian Morrissey
In this interview we spoke to Brian Morrissey, General Manager of Gaelic Laboratories, about the strategy behind their acquisition of Athlone Laboratories, and its impact. read more
Post-Approval Change Management
Achieving global approval for a single change may take three to five years, but inefficient lifecycle change management rarely registers as a crisis. read more
Five Steps to Smooth Agentic AI Adoption
In agentic AI-enabled labs, AI goes from individual, one-off applications to comprehensive workflow orchestration. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Novogene Europe Expands Single-Cell Sequencing Capability at Cambridge Omics Centre
Monday, July 27, 2026
Novogene Europe announced that it has expanded its single-cell RNA sequencing capability at its Cambridge Omics Centre. This expansion brings single-... read more
Pace Life Sciences Announces Compliant FDA Inspection of Operations in Research Triangle Park, NC
Monday, July 27, 2026
Pace® Life Sciences announced the successful completion of an FDA inspection of its Small Molecule Center of Excellence in Research Triangle Park, ... read more
CluePoints Appoints Martin Magazzolo as Chief Commercial Officer
Monday, July 27, 2026
CluePoints has appointed Martin (Marty) Magazzolo as its new Chief Commercial Officer (CCO). Marty will lead CluePoints' global commercial ... read more
Bora, Onconic Ink Manufacturing Deal for U.S. JAQBO Clinical Program
Thursday, July 23, 2026
Bora Pharmaceuticals and Onconic Therapeutics have signed a manufacturing agreement to support the U.S. clinical development of JAQBO tablets, a ... read more
ImmuPharma Selects Thermo Fisher Scientific Drug Product CDMO for Kapiglucagon Program
Wednesday, July 22, 2026
The selection of Thermo Fisher represents an important Chemistry, Manufacturing and Controls (“CMC”) milestone for the Kapiglucagon program and is ... read more